Graft-versus-host disease (GVHD) frequently affects the gastrointestinal tract and liver after a stem cell transplant using donor cells (allogenic transplant). There are two types of GVHD: acute and chronic. This presentation discusses the incidence, symptoms, risk factors for each and treatment options.
The overall health of the gut microbiome and its organisms can influence the prevalence and severity of graft-versus-host disease. This presentation reviews the causes and mechanisms of how organisms in the gut can affect GVHD and reviews potential strategies to minimize this problem.
La enfermedad de injerto contra huésped del tracto gastrointestinal e hígado es común después de un trasplante de médula ósea o de células madre utilizando células de un donante. Conozca los signos, síntomas y opciones de tratamiento para la EICH gastrointestinal y hepática.
Download Speaker Slides Graft-versus-Host-Disease of the Gastrointestinal Tract and Liver Wednesday, April 21, 2021 Presenter: Karamjeet Singh Sandhu MD, City of Hope Medical Center, Duarte, CA Presentation is 37 minutes
Graft-versus-Host-Disease of the Gastrointestinal Tract and Liver July 12, 2020 Part of the Virtual Celebrating a Second Chance at Life Survivorship Symposium 2020 Presenter: Zachariah DeFilipp MD, Transplant Physician, Massachusetts
In this video, Dr. Amelia Langston discusses: GVHD and its risk Prevention is the Cornerstone of Managing GVHD Acute and Chronic GVHD, Overlap GVHD The GI Tract - A Long
